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Abstract 
Calcium signaling is a key regulator of processes important in differentiation. In colon cancer 
cells differentiation is associated with altered expression of specific isoforms of calcium pumps 
of the endoplasmic reticulum and the plasma membrane, suggesting that differentiation of colon 
cancer cells is associated with a major remodeling of calcium homeostasis. Purinergic and 
neurotensin receptor activation are known regulators of cytosolic free Ca
2+
 levels in colon cancer
cells. This study aimed to assess changes in cytosolic free Ca
2+
 levels in response to ATP and
neurotensin with differentiation induced by sodium butyrate or culturing post-confluence. 
Parameters assessed included peak cytosolic free Ca
2+
 level after activation; time to reach peak
cytosolic free Ca
2+
 and the EC50 of dose response curves. Our results demonstrate that
differentiation of HT-29 colon cancer cells is associated with a remodeling of both ATP and 
neurotensin mediated Ca
2+
 signaling. Neurotensin-mediated calcium signaling appeared more
sensitive to differentiation than ATP-mediated Ca
2+ 
signaling.
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Introduction 
Calcium signaling has an essential role in various stages of tumorigenesis including 
angiogenesis, transcription, cell cycle, motility and differentiation [1]. Differentiation therapy 
has been used to treat some cancers [2], as differentiation can convert malignant cells to a more 
benign phenotype associated with reduced proliferation and in some cases can induce apoptosis 
[3, 4]. A feature of the differentiation of colon cancer cells is altered expression of calcium 
pumps of the endoplasmic reticulum (sarco/endoplasmic reticulum Ca
2+
 ATPases - SERCA) and
plasma membrane (plasma membrane Ca
2+
-ATPase - PMCA) [1]. SERCA3 is elevated in
differentiated colon cancer cells and decreased in clinical colon cancers that are poorly 
differentiated [5, 6]. Similarly, our previous studies show that PMCA4 is increased during HT-29 
colon cancer cell differentiation and down regulated in colon cancer compared to normal colon 
[7, 8]. Despite these studies suggesting that a remodeling of Ca
2+
 signaling occurs as a
consequence of colon cancer cell differentiation, there has been no assessment of the 
consequences of differentiation of colon cancer cells on calcium signals mediated by purinergic 
and neurotensin receptors. 
Adenosine triphosphate (ATP) and neurotensin (NT) activate purinoreceptors and neurotensin 
receptors respectively, and induce Ca
2+
 signaling [9]. The purinoreceptors stimulated by ATP,
are known as P2 receptors and are subdivided into P2X (P2X1-7) and P2Y (P2Y1, P2Y2, P2Y4, 
P2Y11-14) receptors [10-12]. The P2X receptors are Ca
2+
 permeable ion channels that promote the
opening of voltage-dependent Ca
2+
 channels [13 36]. P2Y receptors include G-protein-coupled
receptors (GPCRs) that increase intracellular calcium by activation of phospholipase C, 
formation of IP3 and the subsequent release of Ca
2+
 from intracellular stores [9, 12]. Three
neurotensin receptors have been identified, of which neurotensin receptor 1 (NTS1) and 
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neurotensin receptor 2 (NTS2) are G-protein coupled receptors (GPCR) and induce Ca
2+
 release
from internal stores [14] while neurotensin receptor 3 (NTS3) is a non GPCR which modulates 
NT signaling in HT-29 cells by forming a functional interaction with NTS1 [15]. 
In the leukemia cell line HL-60, differentiation attenuates the Ca
2+
 signal elicited by both ATP
and NT [16, 17]. Increases in intracellular Ca
2+
 ([Ca
2+
]cyt) mediated by ATP are also reduced
during the differentiation of both mouse skeletal muscle [18] and C2C12 myoblast cells [19]. 
Purinoreceptor expression levels are often decreased with differentiation of osteoblasts and 
C2C12 myoblasts [20, 21]. A relationship between differentiation and NT receptor expression 
has been observed in primary cultures of prostate cancer cells derived from patient samples and 
in prostate cancer cell lines [22]. Less differentiated prostate cancer cells lines show increased 
NTS1, whereas more differentiated cells have higher levels of NTS2 [22]. A similar remodeling 
of these signaling pathways may also occur in colon cancer cells. Colon cancers overexpress 
P2Y2, P2Y4 and NTS1 receptors compared to normal colon [23, 24] and decreased NTS1 
expression is a feature of sodium butyrate-mediated differentiation of HT-29 colon cancer cells 
[25]. Despite these observations, Ca
2+
 signaling via NT and ATP has not been explored in the
context of HT-29 colon cancer cell differentiation. 
In the study presented here, differentiation of HT-29 colon cancer cells was induced chemically 
(sodium butyrate) or spontaneously (culturing cells post-confluence) [5] to determine if altered 
Ca
2+
 signaling mediated by ATP and NT is associated with the differentiation of colon cancer
cells. 
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Materials and Methods 
Materials 
Fetal Bovine Serum (FBS) was purchased from JRH Bioscience (Lenexa, KS, USA) and RPMI-
1640 media, L-glutamine, penicillin/streptomycin and fluo-4 AM were from Invitrogen 
(Carlsbad, CA, USA). Black CellBIND surface 96-well plates were obtained from Corning Inc. 
(Corning, NY, USA). Sodium butyrate (NaBt), ATP, NT and all other chemicals were purchased 
from Sigma-Aldrich (St Louis, MO, USA). TaqMan Universal PCR Master Mix and TaqMan 
gene expression assays were from Applied Biosystems (Mulgrave, Victoria, Australia). 
Cell Culture 
HT-29 cells were cultured and maintained in RPMI-1640 media, supplemented with 10% FBS, 
L-glutamine (2 mM), penicillin (100 U/mL)/ streptomycin (100 µg/mL) at 37°C with 5% CO2 as 
previously described [7]. Cell lines were tested 6 monthly for mycoplasma contamination using 
the MycoAlert Mycoplasma Detection Assay (Lonza. Inc., Mt Waverley, Victoria, Australia). 
Differentiation in HT-29 cells 
 Sodium butyrate (NaBt) induced differentiation 
For assessment of mRNA, HT-29 cells were seeded at 2.0 X 10
5
 cells/well in 6-well tissue
culture plates. For measurement of intracellular Ca
2+
 ([Ca
2+
]cyt), HT-29 cells were seeded at 6.3
X 10
3
 cells/well in 96-well black CellBIND surface plates. After 48 h cells were treated with 0 or
3 mM NaBt in fresh culture media for 96 h. 
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 Culturing post-confluence induced differentiation 
For mRNA assessment, HT-29 cells were seeded in 6-well plates at 2.5 X 10
5
 cells/well. For
[Ca
2+
]cyt assessment, HT-29 cells were seeded at 6.3 X 10
3
 cells/well in 96-well black CellBIND
surface plates. After the cells were 95-100% confluent (72 h) the cells were maintained in growth 
media for a further 7-14 days with media changes every third day. 
Real time RT- PCR 
RNA was isolated from undifferentiated and differentiated HT-29 cells using the RNeasy® Plus 
Mini Kit (Qiagen, Clifton Hill, Victoria, Australia) and reverse transcribed using the Omniscript 
RT kit (Qiagen). Real time RT-PCR was performed using TaqMan Universal PCR Master Mix 
and a 7500 Real-Time PCR System. The mRNA expression of target genes were assessed using 
the following TaqMan gene expression assays; Hs00357578_m1 (ALPI). Levels of mRNA were 
normalized to 18S rRNA and relative expression levels were determined using the comparative 
Ct method [8, 26]. 
Measurement of [Ca
2+
]cyt
Levels of [Ca
2+
]cyt in undifferentiated and differentiated HT-29 cells were assessed upon
activation with ATP (1 μM – 1 mM) or NT (1 nM – 1 μM), using Fluo-4, as previously described 
[8]. Data were assessed using ScreenWorks 2.0.0.22 (Molecular Devices) at 1 s intervals for 800 
s and fluorescence was normalized for each treatment by assessing response over baseline which 
is a measure of relative [Ca
2+
]cyt [8]. Maximum relative [Ca
2+
]cyt response and time to reach peak
was calculated using ScreenWorks 2.0.0.22 (Molecular Devices). 
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Statistical analysis 
Statistical significance was assessed as described in individual figure legends. Data analysis 
including calculation of EC50 values was performed using Prism version 5.0.2 for Windows 
(GraphPad Inc). The EC50 was calculated using a nonlinear regression analysis in Prism version 
5.0.2. 
Results 
Confirmation of HT-29 cells differentiation 
To verify that differentiation was induced in the HT-29 colon cancer cells by NaBt and culturing 
post-confluence, mRNA levels of a well-established differentiation marker, intestinal alkaline 
phosphatase (ALPI) in HT-29 cells[7, 27, 28], were assessed. NaBt treatment induced ALPI 
expression by approximately 60-fold (P < 0.05) (Fig. 1a), and culturing post-confluence (day 14) 
increased ALPI mRNA levels by approximately 10 fold (P < 0.05) compared to control (Fig. 1b), 
consistent with previous reports from our group and others [7, 29]. 
Effect of NaBt induced differentiation on Ca
2+
 signaling
To assess purinergic and neurotensin signaling in differentiated colon cancer cells, ATP and NT 
were utilized. HT-29 colon cancer cells were differentiated with NaBt and the cytosolic Ca
2+
responses to the agonists ATP (1.0 mM) and NT (1.0 µM) were assessed. The average [Ca
2+
]cyt
transient shows that differentiation altered the nature of the [Ca
2+
]cyt transient in response to ATP
(Fig. 2a). A significant difference in the maximum response to ATP was not observed (Fig. 2b), 
however, the time to reach peak [Ca
2+
]cyt was significantly decreased in differentiated cells (Fig.
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2c). NT-mediated increases in [Ca
2+
]cyt (Fig. 2e) had a similar time to reach peak (Fig. 2g) for
differentiated and undifferentiated cells, but the maximum response to NT was significantly 
reduced (72%) in differentiated cells (Fig. 2f).  
Differential effects of differentiation on ATP and NT responses were also reflected in the dose 
response curves for both ligands. Dose response curves for maximal [Ca
2+
]cyt response to ATP
showed that NaBt induced differentiation shifted the peak Ca
2+
 dose response curve for ATP to
the left (Fig. 2d). The EC50 decreased from 27.7 µM to 4.31 µM with no change in the maximum 
[Ca
2+
]cyt. In contrast, when differentiated HT-29 cells were treated with NT, the maximal
[Ca
2+
]cyt response was reduced at all concentrations of NT (1 nM - 1 µM); and the EC50
increased from 54.8 nM to 103 nM (Fig. 2h). 
Effect of differentiation induced by culturing post-confluence on Ca
2+
 signaling.
An alternative method of differentiation, culturing post-confluence, was used to further assess 
the effect of colon cancer cell differentiation on Ca
2+
 signaling mediated by ATP and NT. Figure
3a shows the average Ca
2+
 transient for ATP stimulated cells. The maximum response to ATP
was reduced in differentiated cells (Fig. 3b). However, the time to reach peak Ca
2+
 with ATP
stimulation was not affected by differentiation (Fig. 3c). A similar trend was observed for NT 
stimulation (Fig. 3e); decreased maximum Ca
2+
 response in differentiated cells (Fig. 3f), but a
similar time to reach peak [Ca
2+
]cyt for differentiated and undifferentiated cells (Fig. 3g).
Comparison between the two ligands suggests that the decrease in maximum [Ca
2+
]cyt response in
differentiated cells appears to be more pronounced for NT activation compared to ATP 
activation (Fig. 3b and 3f). The maximal Ca
2+
 dose response curves for ATP and NT showed that
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culturing post-confluence mediated differentiation decreased the [Ca
2+
]cyt response for both
agonists (Fig. 3d and 3h). With ATP the EC50 increased from 3.62 µM (2.07 x 10
-6
 – 6.32 x 10-6,
95% confidence interval) to 65.6 µM (32.5 x 10
-6
 – 132.0 x 10-6, 95% confidence interval) and
with NT from 13.4 nM (8.09 x 10
-9
 – 22.2 x 10-9, 95% confidence interval) to 160 nM (34.3 x 10-
9 – 748.0 x 10-9, 95% confidence interval) with differentiation.
Comparison of NT and ATP responses 
To assesses whether the change in response to NT was more pronounced compared to ATP with 
differentiation, the maximum [Ca
2+
]cyt was normalized to ATP for all treatments for NaBt (Fig.
4a) and culturing post-confluence induced differentiation (Fig. 4b). Responses to NT were more 
significantly reduced than to ATP for both NaBt (Fig. 4a) and culturing post-confluence induced 
differentiation (Fig. 4b). 
Discussion  
Altered expression of Ca
2+
 pumps is a well characterized feature of colon cancer cell
differentiation [5, 7] and suggests that a remodeling of Ca
2+
 signaling may be one of the
consequences of differentiation of colon cancer cells. While there is evidence that increases in 
[Ca
2+
]cyt in response to ATP and NT are reduced by differentiation in promyelocytic leukemia
cells [16, 17] and muscle cells [18, 19], such alterations in colon cancer cells during 
differentiation have not been explored. 
The current study used two methods to differentiate HT-29 colon cancer cells and assessed the 
effect of differentiation on Ca
2+
 responses elicited by NT and ATP. The current study
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demonstrated that NaBt induced differentiation and culturing post-confluence both modified 
aspects of the [Ca
2+
]cyt response to ATP. However, the nature of the ATP effect on [Ca
2+
]cyt was
different between the two methods of differentiation. These result suggest that the changes in 
ATP-mediated [Ca
2+
]cyt response may not be a consequence of differentiation per se. NaBt
induced differentiation shifted the dose response curve to ATP to the left and decreased the time 
to peak, without significantly affecting the peak [Ca
2+
]cyt response, whereas, spontaneous
differentiation decreased the maximum [Ca
2+
]cyt response and shifted the dose response curve to
the right. NaBt induced differentiation also significantly decreased the time to reach peak 
[Ca
2+
]cyt after ATP-stimulation, but this was not a feature of post-confluence induced
differentiation. Since NaBt and post-confluence induced differentiation had the opposite effect 
with ATP stimulation (ie NaBt shifted the dose responses curve to the left, and culturing post 
confluency shifted the dose response curve to the right), these differences are not likely due to a 
difference in the degree of differentiation. Furthermore, these differences in the Ca
2+
 response do
not parallel with changes in SERCA3 and PMCA4 expression with differentiation [5, 8]. The 
expression levels of P2Y2 and P2Y4 are lower in normal colon compared to colon cancer [23]. 
However, the current assessment of ATP mediated increases in [Ca
2+
]cyt suggests that this
potential difference in levels of purinergic receptors between differentiated and undifferentiated 
colon cells is not reflected in a consistent functional difference in the assessed HT-29 
differentiation models. A variance in the effect of different differentiation mechanisms is also 
been seen with PMA- versus DMSO-induced differentiation in HL-60 cells where ATP potency 
and efficacy are decreased only in the presence of PMA [16]. 
In contrast to ATP, aspects of changes in the NT [Ca
2+
]cyt response were consistently observed
between the two differentiation methods. NT-mediated increases in [Ca
2+
]cyt were attenuated by
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both NaBt and post-confluence induced differentiation. The reduction in maximum [Ca
2+
]cyt
response for NT but not ATP after NaBt-mediated differentiation demonstrates that the altered 
[Ca
2+
]cyt response is not due to general effects on the receptor activated calcium signaling
cascade; for example reduced endoplasmic reticulum Ca
2+
 levels and/or phospholipase C activity
and 1,4,5 trisphosphate generation. Future studies should explore an explanation for the more 
pronounced effects of differentiation on the [Ca
2+
]cyt response to ATP compared to NT. In
conclusion differentiation of HT-29 colon cancer cells is associated with a remodeling of Ca
2+
signaling and this is in part dependent on the activator, with changes in the [Ca
2+
]cyt response to
NT more pronounced that that for ATP 
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Figure legends 
Figure 1: Assessment of intestinal alkaline phosphatase (ALPI) mRNA levels as a marker of 
differentiation in HT-29 cells. ALPI mRNA levels increased during differentiation induced by 3 
mM sodium butyrate (NaBt) (A) or culturing post-confluence (B). Data are normalized to 18S 
rRNA and are relative to control treated cells or 1 day post-confluence. The data are mean ± 
SEM (n = 3-4) and are representative of two independent experiments and the symbol (*) 
indicates significant difference; P < 0.05 using unpaired t-test. 
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Figure 2: Effect of NaBt induced differentiation on receptor mediated Ca
2+
 signaling.
Assessment of [Ca
2+
]cyt in HT-29 cells treated with 0 or 3 mM NaBt and stimulated with ATP
(A-D) or NT (E-H). A and E, average [Ca
2+
]cyt transient in cells treated with ATP (A) or NT (E).
B and F, Relative peak [Ca
2+
]cyt with ATP (B) or NT (F) stimulation. C and G, time to peak
[Ca
2+
]cyt with ATP (C) or NT (G) stimulation. D and H, concentration response curves for
receptor mediated Ca
2+
 signaling in HT-29 cells stimulated with ATP (1 µM-1 mM) (D) or NT
(1 nM – 1 µM) (H). Insert shows average EC50 values. Data are mean (± SEM; n = 12) and are 
representative of 4 independent assays and symbol (*) indicates significant difference; P < 0.05 
using unpaired t-test. 
Figure 3: Effect of culturing post-confluence induced differentiation on receptor mediated Ca
2+
signaling. Assessment of [Ca
2+
]cyt in HT-29 cells cultured for seven days post-confluence and
stimulated with ATP (A-D) or NT (E-H). A and E, average [Ca
2+
]cyt transient in cells treated
with ATP (A) or NT (D). Data are mean ± SEM (n = 12) and are representative of four 
independent assays. B and E, Relative peak [Ca
2+
]cyt with ATP (B) or NT (F) stimulation. C and
G, time to peak [Ca
2+
]cyt with ATP (C) or NT (G) stimulation. D and H, concentration response
curves for receptor mediated Ca
2+
 signaling in HT-29 cells stimulated with ATP (1 µM-1 mM)
(D) or NT (1 nM – 1 µM) (H). Insert shows average EC50 values. Data are mean +SEM (n = 12) 
dose response curves for relative peak [Ca
2+
]cyt from four independent assays. Insert shows
average EC50 values. Data are mean (± SEM; n = 12) from four independent assays and symbol 
(*) indicates significant difference; P < 0.05 using unpaired t-test. 
Figure 4: Comparison of relative peak [Ca
2+
]cyt in differentiated and undifferentiated HT-29
cells stimulated with ATP or NT. A, normalized relative peak [Ca
2+
]cyt in cells treated with 0 or 3
17 
mM NaBt. B, normalized relative peak [Ca
2+
]cyt in cells cultured for seven days post-confluence.
Data are mean ± SEM (n = 12) from four independent assays and are normalized to the ATP for 
each condition. Symbol (*) indicates significant difference; P < 0.05 using unpaired t-test. 
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